Biological Sciences and Omics
As a leader in the field of integrated omics, PNNL has developed innovative methods and identified critical biomarkers for advancing the detection, diagnosis, and treatment of diseases, such as diabetes, cancer, lymphoma, viruses, and liver fibrosis. These methods enable the development of personalized medicine techniques that can diagnose and treat some of the world’s most challenging diseases. For example, a PNNL-developed antibody is being used to predict and monitor drug responsiveness for asthmatics. We invite you to explore the possibilities of licensing our innovations from the Biological Science & Omics portfolio to make an impact on human and animal health.